Technology plays a critical role in helping patients, and the clinicians and institutions they trust, make every moment matter in the fight against cancer.

With this blog, we aim to explore the challenges faced by the clinical trial and cancer registry communities and bring light to the innovative solutions that are transforming the landscape.

Poor clinical trial accrual is not an “outlier” issue, with 1 in 4 trials failing to enroll enough participants to draw valid...

When asked how Artificial Intelligence (AI) will truly move society forward, most experts include cancer care in their answer....

Cancer centers have known for many years that clinical trial recruitment is a serious problem. But in recent years, a new...

It’s no secret that there has been a growing awareness of the importance of diversity, equity, and inclusion (DE&I) in clinical...

Clinical trial participants hail from all walks of life. They are young and old, representing myriad races and ethnicities, and...

Achieving accrual targets for oncology clinical trials has always been a significant challenge, but more recently, it seems to be...

At Inspirata, we believe that using technology such as Artificial Intelligence (AI) and Natural Language Processing (NLP) to...

During a recent virtual fireside chat, I met with industry experts Courtney Hudson, President and Founder of Carebox; and Cyntha...